NSE · INDRAMEDCO · Healthcare
Indraprastha Medical Corporation Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,379 Cr with net profit ₹161 Cr — a 11.67% net margin, versus 9.83% the period before.
Shareholding
As of 2026-06-30
- Promoter51%
- Public45.65%
- FII2.77%
- DII0.59%
75,098 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.87× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Medical Care Facilities · ranked #1 of 3 by market cap
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Indraprastha Medical Corporation Ltd.(this company) | — | 79.08 | 4.45 | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashIndraprastha Medical Corporation Ltd. provides hospital services in India, including specialties like genomic medicine, bariatric surgery, and oncology. The company was founded in 1983 and is based in New Delhi. It has a market capitalization of Rs 3431 Cr.
Positives
- +The company has a low debt-to-equity ratio of 0.06.
- +Return on Capital Employed (ROCE) is 32.3896%, indicating efficient use of capital.
- +Return on Equity (ROE) is 24.8%, demonstrating good shareholder returns.
- +Promoter shareholding is 50.9998% as of June 30, 2026, indicating significant insider stake.
- +The profit margin is 12.39%, suggesting healthy operational efficiency.
Negatives
- −No annual revenue growth figure was provided in the data.
- −Quarterly EPS figures are not available for any reported quarter.
Business
Indraprastha Medical Corporation Limited offers a wide range of hospital services across various specialties. These include sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, and general and laparoscopic surgery. Additionally, the company provides services in gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, plastic surgery, pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory, interventional, preventive, and sleep medicine services.
Financial Performance
The company reported annual revenue of Rs 1379.01 Cr for Mar 2025. Annual net profit increased from Rs 123.96 Cr in Mar 2024 to Rs 160.99 Cr in Mar 2025. Quarterly revenue was Rs 364.81 Cr for Mar 2026, with a net profit of Rs 41.7 Cr for the same period. EBITDA for Mar 2026 was Rs 56.5 Cr.
Profitability & Returns
Indraprastha Medical Corporation Ltd. reported a profit margin of 12.39%. The return on equity (ROE) stood at 24.8% and return on capital employed (ROCE) was 32.3896%. Earnings per share (EPS) for Mar 2025 was Rs 17.56, up from Rs 13.52 in Mar 2024. The trailing twelve months EPS is Rs 20.03.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0.06. Book value per share is Rs 80.76. There is no information regarding pledge of promoter shares. The dividend yield for the company is 1.07%.
Ownership & Pledges
As of June 30, 2026, promoters held 50.9998% of the shares. Public shareholding was 45.6452%. Foreign institutional investors (FIIs) held 2.7669% and domestic institutional investors (DIIs) held 0.5881%. Total institutional holding was 3.355%. The company has 75098 shareholders. No promoter shares are pledged.
Data as of — price: 2026-07-31 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Indraprastha Medical Corporation Ltd.share price & fundamentals